Inmune Bio (INMB) Other Accumulated Expenses (2017 - 2025)
Inmune Bio's Other Accumulated Expenses came in at $511,000 for Q2 2025, down 1.9% from $521,000 a year earlier but up 6.5% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Other Accumulated Expenses (2017 - 2025) Analysis & Trends
At the end of FY2024, Inmune Bio's Other Accumulated Expenses was $517,000, up 5.7% from FY2023.
- Other Accumulated Expenses carries a five-year compound annual growth rate of 12.3% (FY2019 to FY2024).
- Going back by year, Other Accumulated Expenses was $489,000 in FY2023 (-20.6%), $616,000 in FY2022 (+30.0%), $474,000 in FY2021 (+149.5%) and $190,000 in FY2020 (-34.5%).
- The five-year range for quarterly Other Accumulated Expenses is $190,000 (Q4 2020) to $778,000 (Q3 2022).
- Year-over-year, Other Accumulated Expenses increased in two of the last eight quarters, with an average decline of 8.6%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q4 2021 (growth of 149.5%), and the weakest in Q3 2023 (a decline of 36.2%).
- Business Quant data shows INMB's Other Accumulated Expenses at $480,000 (Q1 2025), $517,000 (Q4 2024) and $549,000 (Q3 2024) in the three quarters before Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Inmune Bio | 53.37 Mn | -38.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 511,000.00 |
| Mar 31, 2025 | 480,000.00 |
| Dec 31, 2024 | 517,000.00 |
| Sep 30, 2024 | 549,000.00 |
| Jun 30, 2024 | 521,000.00 |
| Mar 31, 2024 | 520,000.00 |
| Dec 31, 2023 | 489,000.00 |
| Sep 30, 2023 | 496,000.00 |
| Jun 30, 2023 | 560,000.00 |
| Mar 31, 2023 | 591,000.00 |
| Dec 31, 2022 | 616,000.00 |
| Sep 30, 2022 | 778,000.00 |
| Jun 30, 2022 | 476,000.00 |
| Mar 31, 2022 | 584,000.00 |
| Dec 31, 2021 | 474,000.00 |
| Sep 30, 2021 | 541,000.00 |
| Jun 30, 2021 | 583,000.00 |
| Mar 31, 2021 | 591,000.00 |
| Dec 31, 2020 | 190,000.00 |
| Sep 30, 2020 | 253,709.00 |
API Access
Inmune Bio Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();